Clinical Trial Update: Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two glaucoma drugs over a 24-hour period has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED